Device Week, Nov. 2, 2017 – More M&A, Merck and Med In Ireland

In this edition of Device Week, Medtech Insight’s Tina Tan chats to Catherine Longworth about the recent surge in M&A deal-making and wonder if this would impact 2017’s overall outlook. They also chat about Merck’s ambitions to be an all-round leader in fertility treatment, for both drugs and devices and what makes Ireland continue to be an attractive medtech hub for generating innovation. For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode: Stryker's Deal For Spine Device Maker Vexim Rounds Up Ortho M&A Trilogy http://bit.ly/2hpvIXc Smith & Nephew To Acquire Regenerative Shoulder-Tech Firm http://bit.ly/2gNNBxY Merck On A Mission To Introduce Automation To Fertility Treatment http://bit.ly/2zjbg4v Innovation Driving Ireland's Transition From Medtech Supplier To Strategic Partner http://bit.ly/2xyBU4U